We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Brain Fluid Sensor May Improve Hydrocephalus Treatment

By HospiMedica International staff writers
Posted on 02 Aug 2010
A patented volume sensor could better regulate cerebrospinal fluid (CSF) flow in hydrocephalus patients by accurately measuring intracranial ventricular fluid volume, and keeping it constant using an active feedback control mechanism.

Researchers at the University of Illinois (Chicago, USA) developed a novel impedance sensor for direct brain ventricular CSF volume measurements, based on a model that emulates the expansion of the lateral ventricles, as seen in hydrocephalus. More...
The sensor prototypes were fabricated and tested by injecting CSF into a lab model and withdrawing it cyclically in a controlled manner, with volume measurements tracked over eight hours; the pressure measurements recorded were found to be comparable to conditions seen clinically. The results obtained from the bench-top model served to calibrate the sensor for preliminary animal experiments.

In the second part of the experiment, a hydrocephalic rat model was used to validate a scaled-down, microfabricated prototype sensor. CSF was removed from the enlarged ventricles and a dynamic volume decrease was properly recorded in short-period experiments, measuring the volume of fluid removed over a few hours. The researchers will further assess the animal model over several weeks to see if the tracking of ventricular size is accurate following shunting. The researchers also hope that the new designs will accelerate future medical device design, by determining sensor specifications and optimization in a rational process. The study was published ahead of print on May 24, 2010, in IEEE Transactions of Biomedical Engineering.

"One of the biggest problems with shunts is they either drain too much--so brain ventricles, or cavities, completely collapse--or drain too little,” said lead author Andreas Linninger, Ph.D., an associate professor of bioengineering. "Either way, it's not the best outcome for patients.”

A surgically implanted shunt system that relies on pressure to discharge fluid and diverts excess CSF from the brain to a part of the body where it can be absorbed--usually the abdomen--has long been the preferred treatment for hydrocephalus. But shunts are unreliable and often fail after implantation, since they are passive, affected by posture, activity, and even altitude. Current monitoring options of shunt performance involve magnetic resonance imaging (MRI) or pressure monitors; however, there are no existing methods for continuous cerebral ventricle volume measurements.

Related Links:

University of Illinois




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.